DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

H.C. Wainwright Initiates Coverage On Anavex Life Sciences with Buy Rating, Announces $12 Price Target

H.C. Wainwright analyst Raghuram Selvaraju initiates coverage on Anavex Life Sciences (NASDAQ:AVXL) with a Buy rating and a $12 price target.

Benzinga · 03/16/2020 11:15

H.C. Wainwright analyst Raghuram Selvaraju initiates coverage on Anavex Life Sciences (NASDAQ:AVXL) with a Buy rating and a $12 price target.